Zanamivir for Infants with Complicated Influenza

We are studying how safe and effective intravenous zanamivir is for hospitalized infants under 6 months with complicated influenza. This research aims to understand how the drug works in young children.

>2 years ≤5 visits Efficacy phase (II)No Placebo Cost Reimbursement Standard Medicines InjectionInfectious DiseasesPediatrics

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Dectova

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Zanamivir

Zanamivir is an antiviral substance used to treat and prevent influenza by stopping the virus from spreading in the respiratory tract.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Relenza

Relenza Rotadisks

Реленца

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Azienda Ospedaliera Universitaria Meyer IRCCS

SOC Malattie Infettive Pediatriche

Florence, Italy

Azienda Ospedaliera Universitaria Gaetano Martino Messina

UOC Patologia e TIN

Messina, Italy

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

SC Pediatria Pneumoinfettivologia

Milan, Italy

Sponsor: Glaxosmithkline Research & Development Limited

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.